Decorin interacting network: A comprehensive analysis of decorin-binding partners and their versatile functions

Matrix Biology

Volumn 55, Issue , 2016, Pages 7-21

  Gubbiotti, Maria A ^a   Vallet, Sylvain D ^b   Ricard Blum, Sylvie ^b   Iozzo, Renato V ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Angiogenesis; Autophagy; Binding partners; Decorin; Extracellular matrix; Proteoglycan; Tumorigenesis

Indexed keywords

BINDING PROTEIN; DECORIN; ENZYME; GROWTH FACTOR; LIGAND; MEMBRANE PROTEIN; PROTEIN TYROSINE KINASE; PROTEINASE; COLLAGEN; GLYCOSAMINOGLYCAN; PROTEOGLYCAN;

HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; EXTRACELLULAR MATRIX; PHYSIOLOGY;

ANIMALS; COLLAGEN; DECORIN; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS; HUMANS; PROTEIN INTERACTION MAPS; PROTEOGLYCANS; SIGNAL TRANSDUCTION;

EID: 84992187693     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2016.09.009     Document Type: Review

References (179)

1. [1] Iozzo, R.V., The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit. Rev. Biochem. Mol. Biol. 32 (1997), 141–174.
2. [2] Iozzo, R.V., Schaefer, L., Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J. 277 (2010), 3864–3875.
3. [3] Iozzo, R.V., Sanderson, R.D., Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J. Cell. Mol. Med. 15 (2011), 1013–1031.
4. [4] Naba, A., Clauser, K.R., Ding, H., Whittaker, C.A., Carr, S.A., Hynes, R.O., The extracellular matrix: tools and insights for the “omics” era. Matrix Biol. 49 (2016), 10–24.
5. [5] Iozzo, R.V., Schaefer, L., Proteoglycan form and function: a comprehensive nomenclature of proteoglycans. Matrix Biol. 42 (2015), 11–55.
6. [6] Danielson, K.G., Fazzio, A., Cohen, I., Cannizzaro, L.A., Eichstetter, I., Iozzo, R.V., The human decorin gene: intron-exon organization, discovery of two alternatively spliced exons in the 5' untranslated region, and mapping of the gene to chromosome 12q23. Genomics 15 (1993), 146–160.
7. [7] Keene, D.R., San Antonio, J.D., Mayne, R., McQuillan, D.J., Sarris, G., Santoro, S.A., et al. Decorin binds near the C terminus of type I collagen. J. Biol. Chem. 275 (2000), 21801–21804.
8. [8] Reed, C.C., Iozzo, R.V., The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj. J. 19 (2002), 249–255.
9. [9] Rühland, C., Schönherr, E., Robenek, H., Hansen, U., Iozzo, R.V., Bruckner, P., et al. The glycosaminoglycan chain of decorin plays an important role in collagen fibril formation at the early stages of fibrillogenesis. FEBS J. 274 (2007), 4246–4255.
10. [10] Robinson, P.S., Lin, T.W., Jawad, A.F., Iozzo, R.V., Soslowsky, L.J., Investigating tendon fascicle structure–function relationship in a transgenic age mouse model using multiple regression models. Ann. Biomed. Eng. 32 (2004), 924–931.
11. [11] Sanches, J.C.T., Jones, C.J.P., Aplin, J.D., Iozzo, R.V., Zorn, T.M.T., Oliveira, S.F., Collagen fibril organization in the pregnant endometrium of decorin-deficient mice. J. Anat. 216 (2010), 144–155.
12. [12] Weber, I.T., Harrison, R.W., Iozzo, R.V., Model structure of decorin and implications for collagen fibrillogenesis. J. Biol. Chem. 271 (1996), 31767–31770.
13. [13] Nikolovska, K., Renke, J.K., Jungmann, O., Grobe, K., Iozzo, R.V., Zamfir, A.D., et al. A decorin-deficient matrix affects skin chondroitin/dermatan sulfate levels and keratinocyte function. Matrix Biol. 35 (2014), 91–102.
14. [14] Chen, S., Young, M.F., Chakravarti, S., Birk, D.E., Interclass small leucine-rich repeat proteoglycan interactions regulate collagen fibrillogenesis and corneal stromal assembly. Matrix Biol. 35 (2014), 103–111.
15. [15] Wu, Z., Horgan, C.E., Carr, O., Owens, R.T., Iozzo, R.V., Lechner, B.E., Biglycan and decorin differentially regulate signaling in the fetal membranes. Matrix Biol. 35 (2014), 266–275.
16. [16] Dunkman, A.A., Buckley, M.R., Mienaltowski, M.J., Adams, S.M., Thomas, S.J., Kumar, A., et al. The injury response of aged tendons in the absence of biglycan and decorin. Matrix Biol. 35 (2014), 232–238.
17. [17] Häkkinen, L., Strassburger, S., Kahari, V.M., Scott, P.G., Eichstetter, I., Iozzo, R.V., et al. A role for decorin in the structural organization of periodontal ligament. Lab. Investig. 80 (2000), 1869–1880.
18. [18] Ichii, M., Frank, M.B., Iozzo, R.V., Kincade, P.W., The canonical Wnt pathway shapes niches supportive of hematopoietic stem/progenitor cells. Blood 119 (2012), 1683–1692.
19. [19] Järveläinen, H., Sainio, A., Wight, T.N., Pivotal role for decorin in angiogenesis. Matrix Biol. 43 (2015), 15–26.
20. [20] Neill, T., Painter, H., Buraschi, S., Owens, R.T., Lisanti, M.P., Schaefer, L., et al. Decorin antagonizes the angiogenic network. Concurrent inhibition of Met, hypoxia inducible factor-1α and vascular endothelial growth factor a and induction of thrombospondin-1 and TIMP3. J. Biol. Chem. 287 (2012), 5492–5506.
21. [21] Weis, S.M., Zimmerman, S.D., Shah, M., Covell, J.W., Omens, J.H., Ross, J. Jr., et al. A role for decorin in the remodeling of myocardial infarction. Matrix Biol. 24 (2005), 313–324.
22. [22] Frey, T., Schroeder, N., Manon-Jensen, T., Iozzo, R.V., Schaefer, L., Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS J. 280 (2013), 2165–2179.
23. [23] Bocian, C., Urbanowitz, A.K., Owens, R.T., Iozzo, R.V., Gotte, M., Seidler, D.G., Decorin potentiates interferon-gamma activity in a model of allergic inflammation. J. Biol. Chem. 288 (2013), 12699–12711.
24. [24] Borges, M.C., Narayanan, V., Iozzo, R.V., Ludwig, M.S., Deficiency of decorin induces expression of Foxp3 in CD4(+) CD25(+) T cells in a murine model of allergic asthma. Respirology 20 (2015), 904–911.
25. [25] Williams, K.J., Qiu, G., Usui, H.K., Dunn, S.R., McCue, P., Bottinger, E., et al. Decorin deficiency enhances progressive nephropathy in diabetic mice. Am. J. Pathol. 171 (2007), 1441–1450.
26. [26] Baghy, K., Iozzo, R.V., Kovalszky, I., Decorin-TGFβ axis in hepatic fibrosis and cirrhosis. J. Histochem. Cytochem. 60 (2012), 262–268.
27. [27] Järveläinen, H., Puolakkainen, P., Pakkanen, S., Brown, E.L., Höök, M., Iozzo, R.V., et al. A role for decorin in cutaneous wound healing and angiogenesis. Wound Repair Regen. 14 (2006), 443–452.
28. [28] Gubbiotti, M.A., Neill, T., Frey, H., Schaefer, L., Iozzo, R.V., Decorin is an autophagy-inducible proteoglycan and is required for proper in vivo autophagy. Matrix Biol. 48 (2015), 14–25.
29. [29] Neill, T., Torres, A.T., Buraschi, S., Iozzo, R.V., Decorin has an appetite for endothelial cell autophagy. Autophagy 9 (2013), 1626–1628.
30. [30] Buraschi, S., Neill, T., Goyal, A., Poluzzi, C., Smythies, J., Owens, R.T., et al. Decorin causes autophagy in endothelial cells via Peg3. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), E2582–E2591.
31. [31] Gubbiotti, M.A., Iozzo, R.V., Proteoglycans regulate autophagy via outside-in signaling: an emerging new concept. Matrix Biol. 48 (2015), 6–13.
32. [32] Goyal, A., Neill, T., Owens, R.T., Schaefer, L., Iozzo, R.V., Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells. Matrix Biol. 34 (2014), 46–54.
33. [33] Dellett, M., Hu, W., Papadaki, V., Ohnuma, S., Small leucine rich proteoglycan family regulates multiple signalling pathways in neural development and maintenance. Develop. Growth Differ. 54 (2012), 327–340.
34. [34] Buraschi, S., Pal, N., Tyler-Rubinstein, N., Owens, R.T., Neill, T., Iozzo, R.V., Decorin antagonizes met receptor activity and downregulates β-catenin and Myc levels. J. Biol. Chem. 285 (2010), 42075–42085.
35. [35] Csordás, G., Santra, M., Reed, C.C., Eichstetter, I., McQuillan, D.J., Gross, D., et al. Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J. Biol. Chem. 275 (2000), 32879–32887.
36. [36] Goldoni, S., Humphries, A., Nyström, A., Sattar, S., Owens, R.T., McQuillan, D.J., et al. Decorin is a novel antagonistic ligand of the Met receptor. J. Cell Biol. 185 (2009), 743–754.
37. [37] Iozzo, R.V., Moscatello, D., McQuillan, D.J., Eichstetter, I., Decorin is a biological ligand for the epidermal growth factor receptor. J. Biol. Chem. 274 (1999), 4489–4492.
38. [38] Ferdous, Z., Wei, V.M., Iozzo, R.V., Höök, M., Grande-Allen, K.J., Decorin-transforming growth factor-ß interaction regulates matrix organization and mechanical characteristics of three-dimensional collagen matrices. J. Biol. Chem. 282 (2007), 35887–35898.
39. [39] Jarvinen, T.A., Prince, S., Decorin: a growth factor antagonist for tumor growth inhibition. Biomed. Res. Int., 2015, 2015, 654765.
40. [40] Markmann, A., Hausser, H., Schonherr, E., Kresse, H., Influence of decorin expression on transforming growth factor-beta-mediated collagen gel retraction and biglycan induction. Matrix Biol. 19 (2000), 631–636.
41. [41] Vial, C., Gutierrez, J., Santander, C., Cabrera, D., Brandan, E., Decorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activity. J. Biol. Chem. 286 (2011), 24242–24252.
42. [42] Baghy, K., Horváth, Z., Regõs, E., Kiss, K., Schaff, Z., Iozzo, R.V., et al. Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis. FEBS J. 280 (2013), 2150–2164.
43. [43] Baghy, K., Tatrai, P., Regos, E., Kovalszky, I., Proteoglycans in liver cancer. World J. Gastroenterol. 22 (2016), 379–393.
44. [44] Mimura, T., Han, K.Y., Onguchi, T., Chang, J.-H., Kim, T.-I., Kojima, T., et al. MT1-MMP-mediated cleavage of decorin in corneal angiogenesis. J. Vasc. Res. 46 (2008), 541–550.
45. [45] Scott, J.E., Proteodermatan and proteokeratan sulfate (decorin, lumican/fibromodulin) proteins are horseshoe shaped. Implications for their interactions with collagen. Biochemistry 35 (1996), 8795–8799.
46. [46] Scott, P.G., McEwan, P.A., Dodd, C.M., Bergmann, E.M., Bishop, P.N., Bella, J., Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 15633–15638.
47. [47] Svensson, L., Heinegård, D., Oldberg, Å., Decorin binding sites for collagen type I are mainly located in leucine rich repeats 4–5. J. Biol. Chem. 270 (1995), 20712–20716.
48. [48] Khan, G.A., Girish, G.V., Lala, N., DiGuglielmo, G.M., Lala, P.K., Decorin is a novel VEGFR-2-binding antagonist for the human extravillous trophoblast. Mol. Endocrinol. 25 (2011), 1431–1443.
49. [49] Santra, M., Reed, C.C., Iozzo, R.V., Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping with but distinct from the EGF-binding epitope. J. Biol. Chem. 277 (2002), 35671–35681.
50. [50] Islam, M., Gor, J., Perkins, S.J., Ishikawa, Y., Bãchinger, H.S., Hohenester, E., The concave face of decorin mediates reversible dimerization and collagen binding. J. Biol. Chem. 288 (2013), 35526–35533.
51. [51] Goldoni, S., Owens, R.T., McQuillan, D.J., Shriver, Z., Sasisekharan, R., Birk, D.E., et al. Biologically active decorin is a monomer in solution. J. Biol. Chem. 279 (2004), 6606–6612.
52. [52] Bredrup, C., Knappskog, P.M., Majewski, J., Rødahl, E., Boman, H., Congenital stromal dystrophy of the cornea caused by a mutation in the decorin gene. Invest. Ophthalmol. Vis. Sci. 46 (2005), 420–426.
53. [53] Kim, J.-H., Ko, J.M., Lee, I., Kim, J.Y., Kim, M.J., Tchah, H., A novel mutation of the decorin gene identified in a Korean family with congenial hereditary stromal dystrophy. Cornea 30 (2011), 1473–1477.
54. [54] Rødahl, E., Van Ginderdeuren, R., Knappskog, P.M., Bredrup, C., Boman, H., A second decorin frame shift mutation in a family with congenital stromal corneal dystrophy. Am. J. Opthalmol. 142 (2006), 520–521.
55. [55] Chen, S., Sun, M., Meng, X., Iozzo, R.V., Kao, W.W.Y., Birk, D.E., Pathophysiological mechanisms of autosomal dominant congenital stromal corneal dystrophy. C-terminal-truncated decorin results in abnormal matrix assembly and altered expression of small leucine-rich proteoglycans. Am. J. Pathol. 179 (2011), 2409–2419.
56. [56] Breuer, B., Schmidt, G., Kresse, H., Non-uniform influence of transforming growth factor-β on the biosynthesis of different forms of small chondroitin sulphate/dermatan sulphate proteoglycan. Biochem. J. 269 (1990), 551–554.
57. [57] Mellgren, A.E., Bruland, O., Vedeler, A., Saraste, J., Schonheit, J., Bredrup, C., et al. Development of congenital stromal corneal dystrophy is dependent on export and extracellular deposition of truncated decorin. Invest. Ophthalmol. Vis. Sci. 56 (2015), 2909–2915.
58. [58] Kamma-Lorger, C.S., Pinali, C., Martinez, J.C., Harris, J., Young, R.D., Bredrup, C., et al. Role of decorin core protein in collagen organisation in congenital stromal corneal dystrophy (CSCD). PLoS One, 11, 2016, e0147948.
59. [59] Adany, R., Heimer, R., Caterson, B., Sorrell, J.M., Iozzo, R.V., Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels. J. Biol. Chem. 265 (1990), 11389–11396.
60. [60] Ruoslahti, E., Structure and biology of proteoglycans. Annu. Rev. Cell Biol. 4 (1988), 229–255.
61. [61] Scott, J.E., Dermatan Sulfate Proteoglycans. 1993, Portland Press, London.
62. [62] Scott, J.E., Orford, C.R., Dermatan sulphate-rich proteoglycan associates with rat tail-tendon collagen at the d band in the gap region. Biochem. J. 197 (1981), 213–216.
63. [63] Font, B., Eichenberger, D., Goldschmidt, D., Boutillon, M.-M., Hulmes, D.J.S., Structural requirements for fibromodulin binding to collagen and the control of type I collagen fibrillogenesis. Critical roles for disulphide bonding and the C-terminal region. Eur. J. Biochem. 254 (1998), 580–587.
64. [64] Danielson, K.G., Baribault, H., Holmes, D.F., Graham, H., Kadler, K.E., Iozzo, R.V., Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell Biol. 136 (1997), 729–743.
65. [65] Bidanset, D.J., Guidry, C., Rosenberg, L.C., Choi, H.U., Timpl, R., Höök, M., Binding of the proteoglycan decorin to collagen type VI. J. Biol. Chem. 267 (1992), 5250–5256.
66. [66] Nareyeck, G., Seidler, D.G., Troyer, D., Rauterberg, J., Krese, H., Schönherr, E., Differential interactions of decorin and decorin mutants with type I and type VI collagens. Eur. J. Biochem. 271 (2004), 3389–3398.
67. [67] Font, B., Aubert-Foucher, E., Goldschmidt, D., Eichenberger, D., der Rest, M.v., Binding of collagen XIV with dermatan sulfate side chain of decorin. J. Biol. Chem. 268 (1993), 25015–25018.
68. [68] Font, B., Eichenberger, D., Rosenberg, L.M., der Rest, M.v., Characterization of the interactions of type XII collagen with two small proteoglycans from fetal bovine tendon, decorin and fibromodulin. Matrix Biol. 15 (1996), 341–348.
69. [69] Vogel, K.G., Paulsson, M., Heinegård, D., Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem. J. 223 (1984), 587–597.
70. [70] Ramamurthy, P., Hocking, A.M., McQuillan, D.J., Recombinant decorin glycoforms. Purification and structure. J. Biol. Chem. 271 (1996), 19578–19584.
71. [71] Douglas, T., Hempel, U., Mietrach, C., Viola, M., Vigetti, D., Heinemann, S., et al. Influence of collagen-fibril-based coatings containing decorin and biglycan on osteoblast behavior. J. Biomed. Mater. Res. 84A (2008), 805–816.
72. [72] Wiberg, C., Klatt, A.R., Wagener, R., Paulsson, M., Bateman, J.F., Heinegård, D., et al. Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan. J. Biol. Chem. 278 (2003), 37698–37704.
73. [73] Otten, C., Wagener, R., Paulsson, M., Zaucke, F., Matrilin-3 mutations that cause chondrodysplasias interfere with protein trafficking while a mutation associated with hand osteoarthritis does not. J. Med. Genet. 42 (2005), 774–779.
74. [74] Liu, X., Meng, L., Shi, Q., Liu, S., Cui, C., Hu, S., et al. Dermatopontin promotes adhesion, spreading and migration of cardiac fibroblasts in vitro. Matrix Biol. 32 (2013), 23–31.
75. [75] Takeda, U., Utani, A., Wu, J., Adachi, E., Koseki, H., Taniguchi, M., et al. Targeted disruption of dermatopontin causes abnormal collagen fibrillogenesis. J. Invest. Dermatol. 119 (2002), 678–683.
76. [76] Burch, G.H., Gong, Y., Liu, W., Dettman, R.W., Curry, C.J., Smith, L., et al. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat. Genet. 17 (1997), 104–108.
77. [77] Wallace, D.M., Murphy-Ullrich, J.E., Downs, J.C., O'Brien, C.J., The role of matricellular proteins in glaucoma. Matrix Biol. 37 (2014), 174–182.
78. [78] Elefteriou, F., Exposito, J.-Y., Garrone, R., Lethias, C., Binding of tenascin-X to decorin. FEBS Lett. 495 (2001), 44–47.
79. [79] Trask, B.C., Trask, T.M., Broekelmann, T., Mecham, R.P., The microfibrillar proteins MAGP-1 and fibrillin-1 form a ternary complex with the chondroitin sulfate proteoglycan decorin. Mol. Biol. Cell 11 (2000), 1499–1507.
80. [80] Mecham, R.P., Gibson, M.A., The microfibril-associated glycoproteins (MAGPs) and the microfibrillar niche. Matrix Biol. 47 (2015), 13–33.
81. [81] Sengle, G., Sakai, L.Y., The fibrillin microfibril scaffold: a niche for growth factors and mechanosensation?. Matrix Biol. 47 (2015), 3–12.
82. [82] Hubmacher, D., Apte, S.S., ADAMTS proteins as modulators of microfibril formation and function. Matrix Biol. 47 (2015), 34–43.
83. [83] Robertson, I.B., Horiguchi, M., Zilberberg, L., Dabovic, B., Hadjiolova, K., Rifkin, D.B., Latent TGF-beta-binding proteins. Matrix Biol. 47 (2015), 44–53.
84. [84] Blaauboer, M.E., Boeijen, F.R., Emson, C.L., Turner, S.M., Zandieh-Doulabi, B., Hanemaaijer, R., et al. Extracellular matrix proteins: a positive feedback loop in lung fibrosis?. Matrix Biol. 34 (2014), 170–178.
85. [85] Hinz, B., The extracellular matrix and transforming growth factor-beta1: tale of a strained relationship. Matrix Biol. 47 (2015), 54–65.
86. [86] Reinboth, B., Hanssen, E., Cleary, E.G., Gibson, M.A., Molecular interactions of biglycan and decorin with elastic fiber components: biglycan forms a ternary complex with tropoelastin and microfibril-associated glycoprotein 1. J. Biol. Chem. 277 (2002), 3950–3957.
87. [87] Schmidt, G., Hausser, H., Kresse, H., Interaction of the small proteoglycan decorin with fibronectin. Involvement of the sequence NKISK of the core protein. Biochem. J. 280 (1991), 411–414.
88. [88] Winnemöller, M., Schmidt, G., Kresse, H., Influence of decorin on fibroblast adhesion to fibronectin. Eur. J. Cell Biol. 54 (1991), 10–17.
89. [89] Winnemöller, M., Schön, P., Vischer, P., Kresse, H., Interactions between thrombospondin and the small proteoglycan decorin: interference with cell attachment. Eur. J. Cell Biol. 59 (1992), 47–55.
90. [90] de Lange Davies, C., Melder, R.J., Munn, L.L., Mouta-Carreira, C., Jain, R.K., Boucher, Y., Decorin inhibits endothelial migration and tube-like structure formation: role of thrombospondin-1. Microvasc. Res. 62 (2001), 26–42.
91. [91] Murphy-Ullrich, J.E., Iozzo, R.V., Thrombospondins in physiology and disease: new tricks for old dogs. Matrix Biol. 31 (2012), 152–154.
92. [92] Murphy-Ullrich, J.E., Sage, E.H., Revisiting the matricellular concept. Matrix Biol. 37 (2014), 1–14.
93. [93] Soto-Pantoja, D.R., Shih, H.B., Maxhimer, J.B., Cook, K.L., Ghosh, A., Isenberg, J.S., et al. Thrombospondin-1 and CD47 signaling regulate healing of thermal injury in mice. Matrix Biol. 37 (2014), 25–34.
94. [94] Resovi, A., Pinessi, D., Chiorino, G., Taraboletti, G., Current understanding of the thrombospondin-1 interactome. Matrix Biol. 37 (2014), 83–91.
95. [95] Rogers, N.M., Sharifi-Sanjani, M., Csanyi, G., Pagano, P.J., Isenberg, J.S., Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease. Matrix Biol. 37 (2014), 92–101.
96. [96] Duquette, M., Nadler, M., Okuhara, D., Thompson, J., Shuttleworth, T., Lawler, J., Members of the thrombospondin gene family bind stromal interaction molecule 1 and regulate calcium channel activity. Matrix Biol. 37 (2014), 15–24.
97. [97] Stenina-Adognravi, O., Invoking the power of thrombospondins: regulation of thrombospondins expression. Matrix Biol. 37 (2014), 69–82.
98. [98] Klee, S., Lehmann, M., Wagner, D.E., Baarsma, H.A., Konigshoff, M., WISP1 mediates IL-6-dependent proliferation in primary human lung fibroblasts. Sci. Rep., 6, 2016, 20547.
99. [99] Desnoyers, L., Arnott, D., Pennica, D., WISP-1 binds to decorin and biglycan. J. Biol. Chem. 276 (2001), 47599–47607.
100. [100] McArthur, M.E., Irving-Rodgers, H.F., Byer, S., Rodgers, R.J., Identification and immunolocalization of decorin, versican, perlecan, nidogen and chondroitin sulfate proteoglycans in bovine small-antral ovarian follicles. Biol. Reprod. 63 (2000), 913–924.
101. [101] Wight, T.N., Kang, I., Merrilees, M.J., Versican and the control of inflammation. Matrix Biol. 35 (2014), 152–161.
102. [102] Wight, T.N., Kinsella, M.G., Evanko, S.P., Potter-Perigo, S., Merrilees, M.J., Versican and the regulation of cell phenotype in disease. Biochim. Biophys. Acta 1840 (2014), 2441–2451.
103. [103] Chang, M.Y., Tanino, Y., Vidova, V., Kinsella, M.G., Chan, C.K., Johnson, P.Y., et al. Reprint of: a rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease. Matrix Biol. 35 (2014), 162–173.
104. [104] Ning, L., Xu, Z., Furuya, N., Nonaka, R., Yamada, Y., Arikawa-Hirasawa, E., Perlecan inhibits autophagy to maintain muscle homeostasis in mouse soleus muscle. Matrix Biol. 48 (2015), 26–35.
105. [105] Grindel, B.J., Martinez, J.R., Pennington, C.L., Muldoon, M., Stave, J., Chung, L.W., et al. Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior. Matrix Biol. 36 (2014), 64–76.
106. [106] Lord, M.S., Chuang, C.Y., Melrose, J., Davies, M.J., Iozzo, R.V., Whitelock, J.M., The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling. Matrix Biol. 35 (2014), 112–122.
107. [107] Farach-Carson, M.C., Warren, C.R., Harrington, D.A., Carson, D.D., Border patrol:insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders. Matrix Biol. 34 (2014), 64–79.
108. [108] Brown, E.L., Wooten, R.M., Johnson, B.J.B., Iozzo, R.V., Smith, A., Dolan, M.C., et al. Resistance to Lyme disease in decorin-deficient mice. J. Clin. Invest. 107 (2001), 845–852.
109. [109] Guo, B., Norris, S., Rosenberg, L.C., Höök, M., Adherence of Borrelia burgdorferi to the proteoglycan decorin. Infect. Immun. 63 (1995), 3467–3472.
110. [110] Shi, Y., Xu, Q., McShan, K., Liang, F.T., Both decorin-binding proteins A and B are critical for the overall virulence of Borrelia burgdorferi. Infect. Immun. 76 (2008), 1239–1246.
111. [111] Moscatello, D.K., Santra, M., Mann, D.M., McQuillan, D.J., Wong, A.J., Iozzo, R.V., Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J. Clin. Invest. 101 (1998), 406–412.
112. [112] Zhu, J.-X., Goldoni, S., Bix, G., Owens, R.A., McQuillan, D., Reed, C.C., et al. Decorin evokes protracted internalization and degradation of the EGF receptor via caveolar endocytosis. J. Biol. Chem. 280 (2005), 32468–32479.
113. [113] Goldoni, S., Seidler, D.G., Heath, J., Fassan, M., Baffa, R., Thakur, M.L., et al. An anti-metastatic role for decorin in breast cancer. Am. J. Pathol. 173 (2008), 844–855.
114. [114] Goldoni, S., Iozzo, R.V., Tumor microenvironment: modulation by decorin and related molecules harboring leucine-rich tandem motifs. Int. J. Cancer 123 (2008), 2473–2479.
115. [115] Neill, T., Torres, A., Buraschi, S., Owens, R.T., Hoek, J., Baffa, R., et al. Decorin induces mitophagy in breast carcinoma cells via peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and mitostatin. J. Biol. Chem. 289 (2014), 4952–4968.
116. [116] Iozzo, R.V., Buraschi, S., Genua, M., Xu, S.-Q., Solomides, C.C., Peiper, S.C., et al. Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling. J. Biol. Chem. 286 (2011), 34712–34721.
117. [117] Morcavallo, A., Buraschi, S., Xu, S.-Q., Belfiore, A., Schaefer, L., Iozzo, R.V., et al. Decorin differentially modulates the activity of insulin receptor isoform A ligands. Matrix Biol. 35 (2014), 82–90.
118. [118] Morrione, A., Neill, T., Iozzo, R.V., Dichotomy of decorin activity on the insulin-like growth factor-I system. FEBS J. 280 (2013), 2138–2149.
119. [119] Lala, N., Gannareddy, V.G., Cloutier-Bosworth, A., Lala, P.K., Mechanisms in decorin regulation of vascular endothelial growth factor-induced human trophoblast migration and acquisition of endothelial phenotype. Biol. Reprod. 87:59 (2012), 1–14.
120. [120] Moreth, K., Iozzo, R.V., Schaefer, L., Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation. Cell Cycle 11 (2012), 2084–2091.
121. [121] Schaefer, L., Iozzo, R.V., Small leucine-rich proteoglycans, at the crossroad of cancer growth and inflammation. Curr. Opin. Genet. Dev. 22 (2012), 56–57.
122. [122] Santiago-García, J., Kodama, T., Pitas, R.E., The class A scavenger receptor binds to proteoglycans and mediates adhesion of macrophages to the extracellular matrix. J. Biol. Chem. 278 (2003), 6942–6946.
123. [123] de Winther, M.P., van Dijk, K.W., Havekes, L.M., Hofker, M.H., Macrophage scavenger receptor class A: a multifunctional receptor in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 20 (2000), 290–297.
124. [124] Myren, M., Kirby, D.J., Noonan, M.L., Maeda, A., Owens, R.T., Ricard-Blum, S., et al. Biglycan potentially regulates angiogenesis during fracture repair by altering expression and function of endostatin. Matrix Biol. 52-54 (2016), 141–150.
125. [125] Brandan, E., Retamal, C., Cabello-Verrugio, C., Marzolo, M.-P., The low density lipoprotein receptor-related protein functions as an endocytic receptor for decorin. J. Biol. Chem. 281 (2006), 31562–31571.
126. [126] Cabello-Verrugio, C., Brandan, E., A novel modulatory mechanism of transforming growth factor-β signaling through decorin and LRP-1. J. Biol. Chem. 282 (2007), 18842–18850.
127. [127] Cabello-Verrugio, C., Santander, C., Cofre, C., Acuna, M.J., Melo, F., Brandan, E., The internal region leucine-rich repeat 6 of decorin interacts with low density lipoprotein receptor-related protein-1, modulates transforming growth factor (TGF)-beta-dependent signaling, and inhibits TGF-beta-dependent fibrotic response in skeletal muscles. J. Biol. Chem. 287 (2012), 6773–6787.
128. [128] Brandan, E., Cabello-Verrugio, C., Vial, C., Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy. Matrix Biol. 27 (2008), 700–708.
129. [129] Jungmann, O., Nikolovska, K., Stock, C., Schulz, J.-N., Eckes, B., Riethmüller, C., et al. The dermatan sulfate proteoglycan decorin modulates α2β1 integrin and vimentin intermediate filament system during collagen synthesis. PLoS One, 7, 2012, e50809.
130. [130] Delogu, G., Brennan, M.J., Functional domains present in the mycobacterial hemagglutinin, HBHA. J. Bacteriol. 181 (1999), 7464–7469.
131. [131] Takeuchi, Y., Kodama, Y., Matsumoto, T., Bone matrix decorin binds transforming growth factor-β and enhances its bioactivity. J. Biol. Chem. 269 (1994), 32634–32638.
132. [132] Kolb, M., Margetts, P.J., Sime, P.J., Gauldie, J., Proteoblycans decorin and biglycan differentially modulate TGF-β-mediated fibrotic responses in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 280 (2001), L1327–L1334.
133. 2 +-dependent phosphorylation of Smad2 at serine-240. Biochem. J. 362 (2002), 643–649.
134. [134] Mauviel, A., Santra, M., Chen, Y.Q., Uitto, J., Iozzo, R.V., Transcriptional regulation of decorin gene expression. Induction by quiescence and repression by tumor necrosis factor-α. J. Biol. Chem. 270 (1995), 11692–11700.
135. [135] Lee, S.-J., Regulation of muscle mass by myostatin. Annu. Rev. Cell Dev. Biol. 20 (2004), 61–86.
136. [136] Miura, T., Kishioka, Y., Wakamatsu, J., Hattori, A., Hennebry, A., Berry, C.J., et al. Decorin binds myostatin and modulates its activity to muscle cells. Biochem. Biophys. Res. Commun. 340 (2006), 675–680.
137. [137] Lipson, K.E., Wong, C., Teng, Y., Spong, S., CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. Fibrogenesis Tissue Repair, 5, 2012, S24.
138. [138] Bi, X., Xia, X., Fan, D., Mu, T., Zhang, Q., Iozzo, R.V., et al. Oncogenic activin C interacts with decorin in colorectal cancer in vivo and in vitro. Mol. Carcinog., 2015.
139. [139] Tufvesson, E., Westergren-Thorsson, G., Tumor necrosis factor-α interacts with biglycan and decorin. FEBS Lett. 530 (2002), 124–128.
140. [140] Horvath, Z., Kovalszky, I., Fullar, A., Kiss, K., Schaff, Z., Iozzo, R.V., et al. Decorin deficiency promotes hepatic carcinogenesis. Matrix Biol. 35 (2014), 194–205.
141. [141] Morrione, A., Valentinis, B., Xu, S.-Q., Yumet, G., Louvi, A., Louvi, A., et al. Insulin-like growth factor II stimulates cell proliferation through the insulin receptor. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 3777–3782.
142. [142] Seidler, D.G., Dreier, R., Decorin and its galactosaminoglycan chain: extracellular regulator of cellular function?. IUBMB Life 60 (2008), 729–733.
143. [143] Rohani, M.G., Parks, W.C., Matrix remodeling by MMPs during wound repair. Matrix Biol. 44-46 (2015), 113–121.
144. [144] Itoh, Y., Membrane-type matrix metalloproteinases: their functions and regulations. Matrix Biol. 44-46 (2015), 207–223.
145. [145] Deryugina, E.I., Quigley, J.P., Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature. Matrix Biol. 44-46 (2015), 94–112.
146. [146] Gaffney, J., Solomonov, I., Zehorai, E., Sagi, I., Multilevel regulation of matrix metalloproteinases in tissue homeostasis indicates their molecular specificity in vivo. Matrix Biol. 44-46 (2015), 191–199.
147. [147] Imai, K., Hiramatsu, A., Fukushima, D., Pierschbacher, M.D., Okada, Y., Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem. J. 322:Pt 3 (1997), 809–814.
148. [148] Duarte, S., Baber, J., Fujii, T., Coito, A.J., Matrix metalloproteinases in liver injury, repair and fibrosis. Matrix Biol. 44-46 (2015), 147–156.
149. [149] von Marschall, Z., Fisher, L.W., Decorin is processed by three isoforms of bone morphogenetic protein-1 (BMP1). Biochem. Biophys. Res. Comm. 391 (2010), 1374–1378.
150. [150] Vadon-Le Goff, S., Hulmes, D.J., Moali, C., BMP-1/tolloid-like proteinases synchronize matrix assembly with growth factor activation to promote morphogenesis and tissue remodeling. Matrix Biol. 44-46 (2015), 14–23.
151. [151] Sartipy, P., Johansen, B., Gasvik, K., Hurt-Camejo, E., Molecular basis for the association of group IIA phospholipase A(2) and decorin in human atherosclerotic lesions. Circ. Res. 86 (2000), 707–714.
152. [152] Burke, J.E., Dennis, E.A., Phospholipase A2 structure/function, mechanism, and signaling. J. Lipid Res. 50:Suppl (2009), S237–S242.
153. [153] Guidetti, G., Bertoni, A., Viola, M., Tira, E., Balduini, C., Torti, M., The small proteoglycan decorin supports adhesion and activation of human platelets. Blood 100 (2002), 1707–1714.
154. [154] Reininger, A.J., Function of von Willebrand factor in haemostasis and thrombosis. Haemophilia 14:Suppl 5 (2008), 11–26.
155. [155] Guidetti, G.F., Bartolini, B., Bernardi, B., Tira, M.E., Berndt, M.C., Balduini, C., et al. Binding of von Willebrand factor to the small proteoglycan decorin. FEBS Lett. 574 (2004), 95–100.
156. 2 +-dependent interaction. J. Biol. Chem. 278 (2003), 13655–13662.
157. [157] Dugan, T.A., Yang, V.W.C., McQuillan, D.J., Höök, M., Decorin modulates fibrin assembly and structure. J. Biol. Chem. 281 (2006), 38208–38216.
158. [158] Lackner, C., Boerwinkle, E., Leffert, C.C., Rahmig, T., Hobbs, H.H., Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J. Clin. Invest. 87 (1991), 2153–2161.
159. [159] Klezovitch, O., Edelstein, C., Zhu, L., Scanu, A.M., Apolipoprotein(a) binds via its C-terminal domain to the protein core of the proteoglycan decorin. Implications for the retention of lipoprotein(a) in atherosclerotic lesions. J. Biol. Chem. 273 (1998), 23856–23865.
160. [160] Kovanen, P.T., Pentikäinen, M.O., Decorin links low-density lipoproteins (LDL) to collagen: a novel mechanism for retention of LDL in the atherosclerotic plaque. Trends Cardiovasc. Med. 9 (1999), 86–91.
161. [161] Pentikäinen, M.O., öörni, K., Lassila, R., Kovanen, P.T., The proteoglycan decorin links low density lipoproteins with collagen type I. J. Biol. Chem. 272 (1997), 7633–7638.
162. [162] Nakamura, F., Osborn, T.M., Hartemink, C.A., Hartwig, J.H., Stossel, T.P., Structural basis of filamin A functions. J. Cell Biol. 179 (2007), 1011–1025.
163. [163] Bachmann, A.S., Howard, J.P., Vogel, C.W., Actin-binding protein filamin A is displayed on the surface of human neuroblastoma cells. Cancer Sci. 97 (2006), 1359–1365.
164. [164] Daquinag, A.C., Zhang, Y., Amaya-Manzanares, F., Simmons, P.J., Kolonin, M.G., An isoform of decorin is a resistin receptor on the surface of adipose progenitor cells. Cell Stem Cell 9 (2011), 74–86.
165. [165] Nadesalingam, J., Bernal, A.L., Dodds, A.W., Willis, A.C., Mahoney, D.J., Day, A.J., et al. Identification and characterization of a novel interaction between pulmonary surfactant protein D and decorin. J. Biol. Chem. 278 (2003), 25678–25687.
166. [166] Krumdieck, R., Höök, M., Rosenberg, L.C., Volanakis, J.E., The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex. J. Immunol. 149 (1992), 3695–3701.
167. [167] Sugars, R.V., Waddington, R.J., Embery, G., The interaction of recombinant decorin with α2HS-glycoprotein-implications for structural and functional investigations. Protein Expr. Purif. 25 (2002), 180–188.
168. [168] Neill, T., Schaefer, L., Iozzo, R.V., An oncosuppressive role for decorin. Mol. Cell. Oncol., 2, 2015, e975645.
169. [169] Neill, T., Schaefer, L., Iozzo, R.V., Decoding the matrix: instructive roles of proteoglycan receptors. Biochemistry 54 (2015), 4583–4598.
170. [170] Neill, T., Schaefer, L., Iozzo, R.V., Decorin, a guardian from the matrix. Am. J. Pathol. 181 (2012), 380–387.
171. [171] Theocharis, A.D., Skandalis, S.S., Neill, T., Multhaupt, H.A., Hubo, M., Frey, H., et al. Insights into the key roles of proteoglycans in breast cancer biology and translational medicine. Biochim. Biophys. Acta 1855 (2015), 276–300.
172. [172] Xu, W., Neill, T., Yang, Y., Hu, Z., Cleveland, E., Wu, Y., et al. The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer. Gene Ther. 22 (2015), 31–40.
173. [173] Yang, Y., Xu, W.W., Neill, T., Hu, Z., Wang, C.H., Xiao, X., et al. Systemic delivery of an oncolytic adenovirus expressing decorin for the treatment of breast cancer bone metastases. Hum. Gene Ther. 26 (2015), 813–825.
174. [174] Iozzo, R.V., Chakrani, F., Perrotti, D., McQuillan, D.J., Skorski, T., Calabretta, B., et al. Cooperative action of germline mutations in decorin and p53 accelerates lymphoma tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 3092–3097.
175. [175] Bi, X., Tong, C., Dokendorff, A., Banroft, L., Gallagher, L., Guzman-Hartman, G., et al. Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation. Carcinogenesis 29 (2008), 1435–1440.
176. [176] Bi, X., Pohl, N.M., Yang, G.R., Gou, Y., Guzman, G., Kajdacsy-Balla, A., et al. Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice. Carcinogenesis 33 (2012), 326–330.
177. [177] Buraschi, S., Neill, T., Owens, R.T., Iniguez, L.A., Purkins, G., Vadigepalli, R., et al. Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model. PLoS One, 7, 2012, e45559.
178. [178] Kalas, W., Swiderek, E., Switalska, M., Wietrzyk, J., Rak, J., Strzadala, L., Thrombospondin-1 receptor mediates autophagy of RAS-expressing cancer cells and triggers tumour growth inhibition. Anticancer Res. 33 (2013), 1429–1438.
179. [179] Launay, G., Salza, R., Multedo, D., Thierry-Mieg, N., Ricard-Blum, S., MatrixDB, the extracellular matrix interaction database: updated content, a new navigator and expanded functionalities. Nucleic Acids Res. 43 (2015), D321–D327.